Epilepsia Open
Scope & Guideline
Connecting researchers and clinicians for impactful discoveries.
Introduction
Aims and Scopes
- Clinical Research in Epilepsy:
The journal publishes studies focusing on the clinical aspects of epilepsy, including treatment efficacy, safety profiles of anti-seizure medications, and surgical interventions. This includes observational studies, clinical trials, and systematic reviews that provide insights into patient management. - Genetic and Molecular Studies:
Research that investigates the genetic underpinnings of epilepsy, including the identification of pathogenic variants and their implications for treatment. This area emphasizes the integration of genetics into clinical practice, such as genetic testing and personalized medicine approaches. - Neurophysiology and Neuroimaging:
The journal features studies employing advanced neurophysiological techniques like EEG, SPECT, and MRI to better understand the mechanisms of epilepsy. This includes research on seizure prediction, biomarkers, and the impact of neuroimaging on surgical outcomes. - Psychosocial Aspects of Epilepsy:
Articles addressing the psychosocial impact of epilepsy on patients and their families, including stigma, mental health comorbidities, and quality of life assessments. This aspect highlights the importance of holistic care in epilepsy management. - Innovative Therapies and Interventions:
Research on novel therapeutic approaches, including digital health interventions, dietary therapies (like the ketogenic diet), and neuromodulation techniques such as vagus nerve stimulation. This includes both clinical efficacy studies and pilot trials.
Trending and Emerging
- Digital Health and Telemedicine:
With the rise of digital health technologies, there is an increasing focus on telemedicine and digital interventions for epilepsy management. Studies exploring the effectiveness of mobile apps and online platforms for patient engagement and self-management are becoming more prevalent. - Precision Medicine and Genetic Testing:
The integration of genetic testing into clinical practice for epilepsy is gaining momentum, with more studies focusing on personalized treatment approaches based on individual genetic profiles. This trend is significant as it aligns with the broader movement towards precision medicine. - Long-term Outcomes and Quality of Life Assessments:
There is a growing emphasis on long-term outcomes and quality of life in epilepsy patients. Research is increasingly looking at how treatment impacts not just seizure control but also overall well-being and daily functioning. - Comorbidities in Epilepsy:
Research exploring the relationship between epilepsy and various comorbid conditions, such as psychiatric disorders, cognitive impairment, and metabolic issues, is on the rise. This reflects a holistic approach to understanding the complexities of epilepsy. - Novel Treatment Modalities:
Emerging therapies, including cannabinoids, neuromodulation techniques, and dietary interventions, are gaining attention. Research is focusing on their efficacy and safety, indicating a shift towards exploring alternative treatment options beyond traditional medications.
Declining or Waning
- Historical Perspectives on Epilepsy:
There has been a noticeable reduction in papers focusing on the historical context and evolution of epilepsy as a medical condition, indicating a shift towards more contemporary clinical and scientific studies. - Pharmacokinetics of Older Antiepileptic Drugs:
Research centered on the pharmacokinetics and safety profiles of older anti-seizure medications is less frequent, as newer therapies and their comparative effectiveness take precedence in recent studies. - Epidemiological Studies in Low-Income Regions:
While still relevant, the volume of epidemiological studies focusing on epilepsy in low-resource settings has decreased, suggesting a potential shift towards more localized or specific clinical studies in developed regions. - Basic Science Research in Animal Models:
There is a decline in the publication of studies focusing on basic science research using animal models. This may indicate a trend towards translational research that connects laboratory findings more directly with clinical applications.
Similar Journals
EPILEPSY & BEHAVIOR
Advancing understanding of epilepsy and its behavioral impacts.EPILEPSY & BEHAVIOR is a premier journal dedicated to advancing the field of neurology and behavioral neuroscience, published by Academic Press Inc. Elsevier Science. With a focus on the complex interplay between epilepsy and behavioral disorders, this journal serves as a pivotal platform for researchers, clinicians, and educators alike. The journal holds a commendable position with a Q2 ranking in key categories such as Behavioral Neuroscience and Clinical Neurology, highlighting its influence and contributions to the scientific community. Notably, EPILEPSY & BEHAVIOR is indexed in Scopus, ranking in the top percentiles across various related fields, which underscores the quality and relevance of the research it publishes. As it navigates from its inception in 2000 to its ongoing work into 2024, the journal remains committed to disseminating high-quality research and insights that address critical issues in epilepsy and associated behavioral challenges, providing invaluable resources for ongoing education and innovation in the field.
Movement Disorders Clinical Practice
Championing advancements in neurology and clinical practice.Movement Disorders Clinical Practice, published by WILEY, is an essential peer-reviewed journal dedicated to advancing the understanding and treatment of movement disorders from a clinical perspective. With an ISSN of 2330-1619, this journal serves as a vital resource for researchers, clinicians, and students engaged in neurology and clinical neuroscience. Since its inception in 2014, the journal has established itself within the medical community, currently positioned in the Q2 category for both Neurology and Neurology (Clinical), reflecting its influence and reputation. Although it does not offer open access, the journal is integral for disseminating high-quality research and clinical insights, thereby contributing significantly to improved patient care and outcomes in the field of movement disorders. Based in Hoboken, NJ, it continues to attract contributions from leading experts and aims to foster a deeper understanding and dialogue surrounding contemporary challenges and advancements in movement disorder treatment.
Clinical Obesity
Empowering Change Through Evidence-Based InsightsClinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.
JOURNAL OF CHILD NEUROLOGY
Elevating Knowledge in the Realm of Child NeurologyThe JOURNAL OF CHILD NEUROLOGY is a distinguished publication in the critical fields of neurology and pediatrics, published by SAGE PUBLICATIONS INC. With its ISSN 0883-0738 and E-ISSN 1708-8283, this journal has been a pivotal resource since its inception in 1986, serving the needs of researchers, clinicians, and students dedicated to advancing the understanding and treatment of neurological disorders in children. As evidenced by its impressive Q2 rankings in both Neurology (clinical) and Pediatrics, Perinatology, and Child Health, the journal has established a reputable position within the academic community, ranking in the 75th percentile for pediatrics and the 53rd percentile for clinical neurology. This periodical not only contributes to the body of knowledge in child neurology but also promotes interdisciplinary collaboration, engaging a global audience through innovative research articles and case studies. Although the journal is not open access, it remains committed to disseminating high-quality research aimed at improving pediatric health outcomes, making it an essential read for professionals and researchers dedicated to this crucial area of medicine.
ACTA NEUROLOGICA BELGICA
Shaping the Future of Neurology Since 1959.ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.
Zeitschrift fur Epileptologie
Connecting researchers and practitioners in the fight against epilepsy.Zeitschrift fur Epileptologie is a vital resource in the field of neurology and pediatric healthcare, published by Springer Heidelberg. With its ISSN 1617-6782 and E-ISSN 1610-0646, the journal focuses on the latest research and clinical practices pertaining to epilepsy, catering to an audience that includes researchers, clinicians, and students. Although it currently holds a Q4 ranking in both Neurology (clinical) and Pediatrics categories, the journal's commitment to disseminating key findings and enhancing understanding in these fields positions it as an important contributor to ongoing discussions around epilepsy management and child health. The journal has published continuously from 2005 to 2022, offering both traditional and open-access viewing options that increase its accessibility to a global audience. By maintaining an emphasis on high-quality research, Zeitschrift fur Epileptologie strives to improve patient care and embrace innovations in treatment methodologies.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
Elevating Standards in Cancer Care and ResearchEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY is a pivotal publication in the field of gynecological oncology, dedicated to advancing research and clinical practices. Established in 1980 and published by MRE PRESS, this journal serves as a platform for disseminating high-quality research, reviews, and case studies pertaining to the diagnosis and treatment of gynecological cancers. Although the journal currently operates without an open access option, it remains a valuable resource for professionals seeking to stay abreast of the latest developments and findings within the field. The journal is indexed in both Scopus and other reputable databases, contributing significantly to the ongoing discourse in medicine with a particular focus on obstetrics, gynecology, and oncology, although it has seen a discontinuation in coverage by Scopus post-2021. With an emphasis on rigorous peer-review and scholarly integrity, the EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY continues to play an essential role in fostering knowledge and innovation among researchers, clinicians, and students committed to improving patient outcomes in gynecological health.
Tumori Journal
Pioneering Discoveries for a Cancer-Free Future.Tumori Journal is a distinguished publication in the field of oncology, dedicated to advancing the understanding and treatment of cancer since its inception in 1946. Published by SAGE Publications Ltd, this Italian journal serves as a pivotal platform for researchers, clinicians, and academicians to disseminate cutting-edge findings in cancer research and related areas of medicine. With an impressive record of contributions spanning multiple decades, Tumori Journal aims to foster collaboration and dialogue among professionals in the oncology community. Although classified in the Q4 category for Cancer Research and the Q3 category for both Medicine (miscellaneous) and Oncology as of 2023, the journal continues to draw interest with its rigorous peer-review process and commitment to quality. Researchers are encouraged to explore innovative methodologies and share impactful clinical insights through the journal, which also ranks within the top tiers of Scopus metrics for oncology and cancer research domains. With a growing emphasis on accessible research, Tumori Journal remains an essential resource in the continuous fight against cancer.
Epilepsy & Behavior Reports
Transforming Insights into Actionable Knowledge in Behavioral NeuroscienceEpilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Innovating treatment approaches in epilepsy care.SEIZURE - EUROPEAN JOURNAL OF EPILEPSY is a leading journal published by W B SAUNDERS CO LTD, specializing in the field of epilepsy and seizure disorders. Since its inception in 1992, this journal has committed itself to advancing research and understanding in neurology, achieving a respectable 2023 impact factor reflected by its Q2 rankings in Medicine (miscellaneous), Neurology, and Clinical Neurology categories. With an impressive Scopus ranking that places it in the top 35% of journals in Neuroscience and Neurology, SEIZURE is dedicated to promoting high-quality research and clinical studies that offer insights into epilepsy management and treatment. Although not an open-access journal, it maintains a diverse array of original articles, reviews, and case studies catering to academicians, medical professionals, and students looking to expand their knowledge on epilepsy. This journal is pivotal for those seeking to stay abreast of the latest trends, therapies, and findings in the neuroclinical landscape.